We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+4.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$33B
AUM Growth
+$5.76B
(+21%)
Cap. Flow
+$4.83B
Cap. Flow
% of AUM
14.64%
Top 10 Holdings %
Top 10 Hldgs %
18%
Holding
1,503
New
268
Increased
383
Reduced
361
Closed
471
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
Amazon
AMZN
|
+$436M |
| 3 |
GE Aerospace
GE
|
+$381M |
| 4 |
Royal Bank of Canada
RY
|
+$368M |
| 5 |
Canadian National Railway
CNI
|
+$354M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$365M |
| 2 |
Cisco
CSCO
|
+$266M |
| 3 |
GSK
GSK
|
+$248M |
| 4 |
CVS Health
CVS
|
+$187M |
| 5 |
British American Tobacco
BTI
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.43% |
| 2 | Financials | 19.11% |
| 3 | Healthcare | 13.53% |
| 4 | Consumer Staples | 11.65% |
| 5 | Industrials | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
American International
AIG
$42.1B
| $261M | 0.79% |
4,167,213
+3,144,446
| +307% | +$195M |
|
27
Kimberly-Clark
KMB
$36.9B
| $259M | 0.79% |
2,009,880
+1,514,722
| +306% | +$197M |
|
|
WBA
28
DELISTED
Walgreens Boots Alliance
WBA
| $258M | 0.78% |
3,295,583
+2,718,800
| +471% | +$224M |
|
29
HCA Healthcare
HCA
$86.1B
| $252M | 0.76% |
2,887,684
+580,084
| +25% | +$49.1M |
|
30
Aon
AON
$78.8B
| $249M | 0.75% |
1,873,681
-94,880
| -5% | -$12M |
|
|
CELG
31
DELISTED
Celgene Corp
CELG
| $248M | 0.75% |
1,907,052
+1,787,052
| +1,489% | +$219M |
|
32
NetEase
NTES
$79.6B
| $246M | 0.75% |
4,095,750
-1,393,680
| -25% | -$79.9M |
|
33
Intuit
INTU
$83.9B
| $246M | 0.74% |
1,852,561
+637,400
| +52% | +$82.7M |
|
34
Prudential Financial
PRU
$42B
| $243M | 0.74% |
2,247,204
+737,458
| +49% | +$78.3M |
|
|
35
British American Tobacco
BTI
$131B
| $242M | 0.73% |
3,526,609
-2,418,289
| -41% | -$168M |
|
36
UnitedHealth
UNH
$381B
| $242M | 0.73% |
1,303,068
+300,744
| +30% | +$52.7M |
|
37
Union Pacific
UNP
$178B
| $238M | 0.72% |
2,187,401
+1,627,453
| +291% | +$177M |
|
38
Idexx Laboratories
IDXX
$44B
| $212M | 0.64% |
1,310,660
+392,790
| +43% | +$63.8M |
|
|
RAI
39
DELISTED
Reynolds American Inc
RAI
| $207M | 0.63% |
3,183,519
+792,500
| +33% | +$51.8M |
|
40
Meta Platforms (Facebook)
META
$1.52T
| $200M | 0.61% |
1,325,900
+1,312,700
| +9,945% | +$195M |
|
41
Elevance Health
ELV
$82B
| $200M | 0.61% |
1,063,843
+255,690
| +32% | +$45.9M |
|
42
HP
HPQ
$24B
| $193M | 0.58% |
11,027,484
-1,800,306
| -14% | -$33.1M |
|
43
Thomson Reuters
TRI
$42.6B
| $192M | 0.58% |
3,582,380
-1,085,100
| -23% | -$55.6M |
|
44
iShares MSCI Taiwan ETF
EWT
$9.88B
| $192M | 0.58% |
5,363,038
+1,511,822
| +39% | +$51.9M |
|
45
Philips
PHG
$26B
| $191M | 0.58% |
7,040,552
+1,284,118
| +22% | +$33.6M |
|
46
SiriusXM
SIRI
$10.6B
| $188M | 0.57% |
3,437,384
+1,869,488
| +119% | +$95.5M |
|
47
Bristol-Myers Squibb
BMY
$128B
| $186M | 0.56% |
3,331,549
+3,323,649
| +42,072% | +$181M |
|
|
48
Cisco
CSCO
$448B
| $184M | 0.56% |
5,891,999
-8,174,237
| -58% | -$266M |
|
49
Lockheed Martin
LMT
$134B
| $180M | 0.54% |
647,483
+116,582
| +22% | +$32M |
|
50
Diageo
DEO
$47.4B
| $177M | 0.54% |
1,475,331
+332,046
| +29% | +$39.5M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2017 Portfolio in Review
As of Q2 2017, Arrowstreet Capital held 1,503 positions worth $33B, up 21% from $27.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $4.83B of net new capital in Q2 2017, opening 268 new positions and adding to 383 existing holdings. Its largest new stake was MetLife: 1,568,893 shares worth $76.8M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $266M trimmed.
- Arrowstreet Capital's largest Q2 2017 buy was MetLife: 1,568,893 shares worth $76.8M.
- Arrowstreet Capital added most to Apple in Q2 2017, an estimated $470M increase.
- Arrowstreet Capital's biggest Q2 2017 reduction was Cisco, cutting an estimated $266M.
- Arrowstreet Capital fully exited AT&T in Q2 2017, selling an estimated $365M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $33B portfolio in Q2 2017.
- Arrowstreet Capital opened 268 new positions and closed 471 in Q2 2017.
- Arrowstreet Capital's portfolio value rose 21% quarter-over-quarter to $33B.
Based on Arrowstreet Capital's 13F filing for Q2 2017, filed 15 Aug 2017.